AstraZeneca Acquires KuDOS Pharmaceuticals For $210 Mil.
The purchase provides AstraZeneca’s oncology division with DNA repair inhibitors in clinical, preclinical development.
The purchase provides AstraZeneca’s oncology division with DNA repair inhibitors in clinical, preclinical development.